» Articles » PMID: 1382852

Age-related Immunoreactivity Pattern in Medulloblastoma

Overview
Specialty Pediatrics
Date 1992 Sep 1
PMID 1382852
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Thirty-five paraffin-embedded medulloblastomas (19 from children and 16 from adults; 24 classic medulloblastomas, 10 desmoplastic medulloblastomas, 1 tumor with neuronal differentiation) were examined for reactions with antibodies against glial fibrillary acidic protein (GFAP), cytokeratins KL1 and MNF116, desmin, and vimentin. Only the tumor from the youngest patient, a 152-day-old boy, showed a positive immunoreaction for cytokeratins. Because of this age-related expression of cytokeratins in medulloblastomas primarily in very young children, cytokeratin positivity was interpreted as a sign of tumor immaturity. Five medulloblastomas showed scattered GFAP-positive reactive astrocytes and/or other positive, probably neoplastic, cells. Only two tumors showed GFAP immunoreactivity in unequivocally neoplastic cells. Of six tumors that reacted with vimentin, three showed strong reactivity throughout, one being the tumor from the 152-day-old boy. The remaining three demonstrated nests of vimentin-positive cells with weak or intense somatic immunoreactivity for vimentin. None of the 35 cases showed positivity for desmin; indicating that mesenchymal differentiation is restricted to the rare so-called medullomyoblastomas.

Citing Articles

Exploring the Molecular Complexity of Medulloblastoma: Implications for Diagnosis and Treatment.

Rechberger J, Toll S, Vanbilloen W, Daniels D, Khatua S Diagnostics (Basel). 2023; 13(14).

PMID: 37510143 PMC: 10378552. DOI: 10.3390/diagnostics13142398.


Immune microenvironment of medulloblastoma: The association between its molecular subgroups and potential targeted immunotherapeutic receptors.

Kurdi M, Mulla N, Malibary H, Bamaga A, Fadul M, Faizo E World J Clin Oncol. 2023; 14(3):117-130.

PMID: 37009528 PMC: 10052334. DOI: 10.5306/wjco.v14.i3.117.


Tumor-Associated Macrophages Correlate With Prognosis in Medulloblastoma.

Zhang J, Yuan X, Wang Y, Liu J, Li Z, Li S Front Oncol. 2022; 12:893132.

PMID: 35860588 PMC: 9289152. DOI: 10.3389/fonc.2022.893132.

References
1.
Zimmer C, Figols J, Patt S, Cervos-Navarro J . Cytokeratin expression in a congenital multipotential primitive neuroectodermal tumor. Childs Nerv Syst. 1991; 7(7):405-9. DOI: 10.1007/BF00304208. View

2.
Schindler E, Gullotta F . Glial fibrillary acidic protein in medulloblastomas and other embryonic CNS tumours of children. Virchows Arch A Pathol Anat Histopathol. 1983; 398(3):263-75. DOI: 10.1007/BF00583584. View

3.
Chase D, ENZINGER F, Weiss S, Langloss J . Keratin in epithelioid sarcoma. An immunohistochemical study. Am J Surg Pathol. 1984; 8(6):435-41. DOI: 10.1097/00000478-198406000-00004. View

4.
Velasco M, Ghobrial M, Ross E . Neuron-specific enolase and neurofilament protein as markers of differentiation in medulloblastoma. Surg Neurol. 1985; 23(2):177-82. DOI: 10.1016/0090-3019(85)90340-4. View

5.
Schiffer D, Giordana M, Vigliani M . Brain tumors of childhood: nosological and diagnostic problems. Childs Nerv Syst. 1989; 5(4):220-9. DOI: 10.1007/BF00271023. View